Mitochondrial dynamics regulator

Mitochondrial dynamics regulators are a specialized group of proteins, primarily large GTPases of the dynamin superfamily, that orchestrate the continuous cycles of mitochondrial fusion and fission (Mitochondrial dynamics: overview of molecular mechanisms, 2021; Chaney et al., 2025). The core machinery includes Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2) for outer membrane fusion, Optic Atrophy 1 (OPA1) for inner membrane fusion, and Dynamin-related protein 1 (Drp1) for fission (Rodrigues et al., 2020; Chaney et al., 2025). These processes are vital for maintaining a healthy mitochondrial network, facilitating the exchange of genetic material, and ensuring proper distribution of organelles according to cellular energy demands (Whitley et al., 2019; Functions and dysfunctions of mitochondrial dynamics, 2007). Imbalances in mitochondrial dynamics—often characterized by excessive fission and reduced fusion—are implicated in the pathogenesis of numerous conditions, including neurodegenerative diseases like Parkinson's and Alzheimer's, cardiovascular diseases such as heart failure and ischemia-reperfusion injury, and various cancers (Almannai et al., 2018; Pharmacological agents targeting mitochondrial fusion and fission pathways, 2024; New therapeutics to modulate mitochondrial dynamics, 2015). Consequently, these regulators have emerged as promising therapeutic targets (Drugging mitochondrial dynamics, 2021; Whitley et al., 2019). Pharmacological agents such as Mdivi-1 and P110 aim to inhibit excessive fission, while compounds like M1 and Leflunomide promote fusion (Pharmacological agents targeting mitochondrial fusion and fission pathways, 2024; Novel targets for mitochondrial medicine, 2016). However, the central role of these proteins in global cellular metabolism poses significant challenges for drug development, requiring high specificity to avoid systemic toxicity and unintended disruption of essential mitochondrial functions (Drugging mitochondrial dynamics, 2021; Mitochondrial Targets for Pharmacological Intervention, 2016).

Other names

Mitochondrial fusion and fission proteinsMitochondrial dynamics proteinsMitochondrial quality control proteinsDynamin-related GTPases

Inhibition of mitochondrial fission, promotion of mitochondrial fusion, inhibition of Drp1 GTPase activity, inhibition of Drp1-Fis1 protein-protein interaction, activation of mitofusins, and stabilization of mitochondrial membranes.